baber/WOPTO huggingface dataset:
Patent AU-2021203638-A1 (AU)
Title: Continuous process pyrolysis sytem
Inventor: MORPHETT ADRIAN LINDSAY
IPC: C10B31/08
Filed: 2021-06-03
Abstract: The invention provides apparatus and method of pyrolysing feedstock to 
produce char. A reaction chamber is substantially sealed except for 
one or more inlet ports at a distal end of the reaction chamber 
connectable to a supply of oxygen-containing gas and one or more 
outlet ports at a proximal end of the reaction chamber for release of 
gaseous combustion products. A feedstock advancing mechanism in a 
lower portion of the reaction chamber advances the feedstock laterally 
along the lower portion as it pyrolyses in its progression from the 
proximal end to the distal end. Char is discharged from the distal end 
of the reaction chamber. A control system controls at least the flow 
rate of oxygen containing gas entering the chamber via the inlet port 
in response to the temperature measurements in the reaction chamber so 
that the temperature measurements are appropriate for the production 
of char from the feedstock and so that a zone of volatile gas 
combustion is established in the headspace, involving essentially 
complete consumption of all incoming free oxygen in the headspace 
without contacting the feedstock.
LIl 
r. o
m> 
m 
00
~r1
Patent AU-2021227716-A1 (AU)
Title: A method of and system for calcium scoring of coronary arteries
Inventor: LICKFOLD CASEY JACK
IPC: A61B6/00
Filed: 2021-02-26
Abstract: A method of automatically determining a calcium score for at least one coronary artery is disclosed. The method comprises receiving cardiac non-contrast CT data indicative of a cardiac non-contrast CT scan carried out on a patient, analysing the cardiac non-contrast CT data in a calcified components identifier to detect candidate coronary artery calcified components, and analysing cardiac non-contrast CT data associated with the candidate coronary artery calcified components using a radiomics analyser to determine radiomic characteristics of the candidate coronary artery calcified components. The method also comprises applying machine learning to the determined radiomic characteristics associated with each candidate coronary artery calcified component to identify any calcifications that are located on a coronary artery, analysing the cardiac non-contrast CT data to identify at least one body component in the cardiac non-contrast CT data not associated with a coronary artery of the patient, and using the identified at least one body component in the cardiac non-contrast CT data to remove or avoid misclassification of calcifications on a coronary artery that are located on the at least one identified body component.
Patent AU-2021229133-A1 (AU)
Title: A method and system for pressure pipe drilling cement-mortar lined and coated steel cylinders
Inventor: GAGNON GILLES
IPC: F16L9/14
Filed: 2021-09-06
Abstract: A method for pressure pipe drilling a pipe comprising an exterior layer and an interior layer, the method comprising 
internally lining the pipe with a fluid-tight sheath; drilling a first cavity through the exterior layer until exposing the interior 
layer; injecting a sealant into the first cavity; and drilling a second cavity within the first cavity through the interior layer 
and the fluid-tight sheath.
- -4 
- A 4 
1698 
4 -- -A--.  
f4 
44 a 
144 
4 -
Patent AU-2021232846-A1 (AU)
Title: Abrasion Resistant Lining and Wear Indicator
Inventor: CHEEVERS SCOTT
IPC: F16L57/06
Filed: 2021-09-19
Abstract: ABRASION RESISTANT LINING AND WEAR INDICATOR 
FIELD 
There is disclosed an abrasion resistant lining (10) including an abrasion resistant lining body (12) 
operatively overlying an equipment surface (14) of materials handling equipment (16). The 
abrasion resistant lining has an abrasion resistant lining surface (18) operatively exposed to wear 
action imparted thereon by material passing across the abrasion resistant lining (10). The abrasion 
resistant lining (10) further includes a wear indicator (20) embedded within the abrasion resistant 
lining body (12). The wear indicator (20) including a wear indicator surface operatively adapted 
to provide an indication of the thickness of the abrasion resistant lining body (12).
30 
go-o-2 14~ 
FIGURE 1 
FIGURE 2
Patent AU-2021236442-A1 (AU)
Title: Methods and systems for rapid detection of microorganisms using recombinant bacteriophage
Inventor: ANDERSON DWIGHT LYMAN
IPC: C12Q1/70
Filed: 2021-09-20
Abstract: Disclosed herein are methods and systems for rapid detection of microorganisms in a sample, 
without culturing for enrichment of the microorganism. A modified bacteriophage is also 
disclosed which comprises a non-native indicator gene in the late gene region. The indicator 
product is not a fusion protein. The specificity of infectious agents allows a specific 
microorganism to be targeted, and an indicator signal may be amplified to optimize assay 
sensitivity.
Patent AU-2021241674-A1 (AU)
Title: Hybridization capture methods and compositions
Inventor: WANG ALEXANDRA HUI
IPC: C12Q1/6834
Filed: 2021-03-25
Abstract: Described herein are methods and compositions for improved hybridization capture for enriching for target nucleic acid sequences from a population of nucleic acids. In one aspect, the methods and compositions are useful for Next Generation Sequencing (NGS) applications. The methods and compositions include combining in solution capture probes and target nucleic acid and permitting hybridization of the target nucleic acid to the capture probes under conditions to promote efficient hybridization. Following hybridization, the probe/target complex is immobilized to a capture material while simultaneously incubating at an optimum hybridization temperature. The incubation denatures unwanted nucleic acids from the capture probes further enriching for target nucleic acid.
Patent AU-2021257828-A1 (AU)
Title: Interleaved cryogenic cooling system for quantum computing applications
Inventor: JEFFREY EVAN ROBERT
IPC: G06N10/00
Filed: 2021-04-14
Abstract: A cryogenic cooling system for use in quantum computing applications can include a plurality of cryogenic cooling stages. Each of the plurality of cryogenic cooling stages can include a plurality of interleaved cooling units. The plurality of interleaved cooling units can include a first cooling unit and a second cooling unit. Each of the plurality of interleaved cooling units can have an associated operating temperature range. One or more signal lines that couple one or more classical processors to one or more quantum systems can pass through each of the plurality of interleaved cooling units for each of the plurality of cryogenic cooling stages.
Patent AU-2021291334-A1 (AU)
Title: Method for the increase of workability of a binder composition comprising portland cement, calcined clay, and limestone
Inventor: JUILLAND PATRICK
IPC: C04B28/04
Filed: 2021-06-08
Abstract: The present invention relates to a method for increasing the workability of a binder composition comprising calcined clay, limestone, and Portland cement. Said method comprises a step of adding an admixture comprising at least one PCE and at least one additive selected from the group consisting of sugar acids, sugars, sugar alcohols, and hydroxycarboxylic acids. The invention also relates to an admixture to be used in said method and hardenable compositions, especially concrete and mortar, obtainable by said method.
Patent AU-2021298896-A1 (AU)
Title: Reduction of viral infections
Inventor: MASOOD MOHAMMED ABID
IPC: A61K33/10
Filed: 2021-07-02
Abstract: The present invention relates to a buffer composition having a pH of from 6.7 to 7.9 at a temperature of 37°C, for use in the treatment, prophylactic treatment or amelioration of an airborne viral infection, or for use in reducing viral replication in a subject infected with an airborne virus or exposed to an airborne virus capable of causing an airborne viral infection in the subject. The buffer composition may comprise an N- substituted aminosulphonic acid. The present invention also relates to a method of preparing the buffer composition, and to a concentrate of the buffer composition. The buffer composition can be used in a method of treatment, prophylactic treatment or amelioration of an airborne viral infection in a subject, and a method of reducing viral replication in a subject infected with an airborne virus or exposed to an airborne virus capable of causing an airborne viral infection in the subject. Airborne viruses include RNA viruses, such as coronaviruses, such as MERS-CoV, SARS-CoV, and SARS-CoV-2. The buffer composition can be administered by nasal spray, inhaler or nebulizer, or in the form of a cream, gel or emulsion, and the invention therefore also relates to a nasal spray, inhaler, nebulizer, cream, gel or emulsion comprising the buffer composition. The buffer composition can also be applied to a mask or other face covering thereby reducing the risk of viral infection with an airborne virus, and the invention therefore also relates to a spray comprising the buffer composition. The buffer composition can also be used in a receptacle through which an oxygen-containing gas is bubbled prior to inhalation by a subject, and the invention therefore also relates to a receptacle containing the buffer composition.
Patent AU-2021303291-A1 (AU)
Title: Thermal immersion circulator device
Inventor: SHEN WILLIAM YIN ZHE
IPC: H05B3/80
Filed: 2021-06-30
Abstract: A thermal immersion circulator comprising a housing defining a cavity, a heater comprising a heating element, wherein at least a portion of the heating element is located within the cavity of the housing, a coupling assembly securing the heater within the housing, and a seal isolating the coupling assembly from direct contact with the heater. The heater comprises a side surface having longitudinal axis, a fluid inlet in communication with a fluid outlet, and a fluid heating portion located between the fluid inlet and the fluid outlet. The heater also comprises at least one seal located adjacent the outlet and a heating element wrapped at least partially about the fluid heating portion. The heating element comprises a plurality of resistive bands arranged on the tubular side wall such that a first portion of a resistive band adjacent the fluid outlet is longitudinally spaced further from the fluid outlet than an opposing second portion of the resistive band to reduce transfer of heat generated by the resistive band to the seal whilst heating the fluid substantially along a longitudinal length of the fluid heating portion.
Patent AU-2021322891-A1 (AU)
Title: Oligonucleotide treatment of hepatitis B patients
Inventor: OTTOSEN SØREN
IPC: A61K31/713
Filed: 2021-08-05
Abstract: The present invention provides oligonucleotides for use in the treatment of hepatitis B or hepatitis B virus infection in a human patient.
Patent AU-2021349249-A1 (AU)
Title: Pyrido(4,3-b)indole derivatives and their use as pharmaceuticals
Inventor: FADER LEE
IPC: A61K31/138
Filed: 2021-09-23
Abstract: There is provided a compound of formula (I): or a pharmaceutically acceptable salt, solvate, ester or prodrug thereof. The compound of formula (I) can be useful for the treatment of a disease or condition for which a cGAS inhibitor is indicated. In some embodiments, the compound or its pharmaceutically acceptable salt, solvate, ester or prodrug thereof can be used for the treatment of an autoinflammation or an autoimmune disease such as systemic lupus erythematosus (SLE), Aicardi-Goutieres syndrome (AGS), nonalcoholic steatohepatitis (NASH), Age-dependent macular degeneration, Myocardial infarction, Acute pancreatitis, Ischemic stroke, Sporadic aortic aneurysm and dissection, Chronic lung disease, Inflammatory bowel disease, Parkinson's disease, Traumatic brain injury or Amyotrophic lateral sclerosis (ALS).
Patent AU-2021355481-A1 (AU)
Title: Human pah expression cassette for treatment of pku by liver-directed gene replacement therapy
Inventor: KYOSTIO-MOORE SIRKKA R M
IPC: C12N9/02
Filed: 2021-09-30
Abstract: Provided herein are expression cassettes for expressing a transgene in a liver cell, wherein the transgene encodes a PAH polypeptide. Also provided are methods to treat phenylketonuria (PKU) and/or to reduce levels of phenylalanine in an individual in need thereof. Further provided herein are vectors (e.g., rAAV vectors), viral particles, pharmaceutical compositions and kits for expressing a PAH polypeptide in an individual in need thereof.
Patent AU-2021370656-A1 (AU)
Title: Patient-specific therapeutic predictions through analysis of free text and structured patient records
Inventor: GLASS JACOB L
IPC: A61B5/00
Filed: 2021-10-26
Abstract: Disclosed are systems and methods for retrieving, for a patient with a medical condition, a structured dataset and an unstructured dataset, the structured dataset comprising demographic and clinical data, and the unstructured dataset comprising a report with free-form text of a clinician with respect to a medical procedure (e.g., a test). Analysis may comprise applying natural language processing to the free-form text in the report to generate a plurality of health indicators for the patient. Categorizations corresponding to the medical condition may be generated, and a treatment regimen determined based on drug orders in the structured dataset. Survival modeling may be applied to generate a prediction corresponding to a survival of the patient following administration of a treatment to the patient for the medical condition. A treatment may be selected and administered based on the prediction.
Patent AU-2021371028-A1 (AU)
Title: Compositions and methods for cellular component transfer therapy
Inventor: SINGH MANDEEP
IPC: C12N5/00
Filed: 2021-11-01
Abstract: The present disclosure provides methods for generating retinal cell clusters for use in cellular component transfer therapy, retinal cell clusters generated by such methods, and compositions comprising such retinal cell clusters. The present disclosure also provides uses of the retinal cell clusters and compositions comprising thereof for preventing and/or treating inherited retinal degenerative diseases.
Patent AU-2021371342-A1 (AU)
Title: Peptides and methods of use
Inventor: KRISHNA NEEL
IPC: A61K38/16
Filed: 2021-11-01
Abstract: The present invention provides synthetic peptides. The invention is directed to modifications of a synthetic peptide of 15 amino acids from the Polar Assortant (PA) peptide, which is a scrambled peptide derived from human astrovirus protein. In some embodiments, the invention is directed to peptides that are modifications of PA including sarcosine substitutions at certain amino acid positions that are stapled and/or have D-enantiomeric substitutions of certain amino acids. The invention further provides methods of selecting at least one synthetic peptide for treating various conditions.
Patent AU-2021407531-A1 (AU)
Title: Vehicle recovery equipment storage arrangement
Inventor: GORDON HUGH
IPC: B60D1/18
Filed: 2021-12-22
Abstract: Disclosed herein is a mounting arrangement for securing vehicle recovery equipment to a vehicle. The mounting arrangement comprises a strap extending between a free end and a securable end and the strap is secured to the anchor system at or proximal to the securable end. The free end extends around at least a part of the vehicle recovery equipment to retain the vehicle recovery equipment. The mounting arrangement also comprises a releasable connector for securing towards or proximal the free end of the strap. Loosening of the releasable connector deploys the vehicle recovery equipment. The mounting arrangement comprises an anchor system comprising an anchor strap extending around a part of the vehicle allowing the anchor system to be mounted at different parts of the vehicle. Also disclosed is a method for mounting the vehicle recovery equipment to a vehicle.
Patent AU-2021410717-A1 (AU)
Title: Optimized structural support in catheter insertion systems
Inventor: SPATARO JOE
IPC: A61M25/01
Filed: 2021-12-21
Abstract: Embodiments disclosed herein are directed to catheter placement systems including distally extendable support devices. When placing elongate catheters advanced insertion systems are required to maintain a "touch-free" insertion. Further longer needles are desirable to access deeper veins or penetrate deeper surface tissues. Distally extendable support devices provide columnar support to one of the elongate catheter or the needle to prevent buckling or kinking of the catheter, and maintain the needle tip within a predetermined bending arm distance. This prevents the user from contacting one of the needle or the catheter directly to provide additional support, maintaining a "touch-free" insertion.
Patent AU-2021424131-A1 (AU)
Title: Methods of treatment with s1p receptor modulators
Inventor: BUCHER CHRISTOPH
IPC: A61K31/00
Filed: 2021-01-28
Abstract: The présent invention relates to S1P receptor modulators, preferably mocravimod, for use in treating patients suffering from acute myelogenous leukemia (AML) and who hâve undergone allogeneic hematopoietic stem cell transplantation (HSCT). The invention relates in particular to methods of treating AML in subjects undergoing HSCT, wherein said method comprises daily administering an efficient amount of S1P receptor modulator, preferably mocravimod, to said subject in need thereof, for at least 6 months, preferably at least 12 months.
Patent AU-2021428218-A1 (AU)
Title: Method and device for producing products from warm dough
Inventor: LÓPEZ FUERIS JUAN IGNACIO
IPC: A23P10/00
Filed: 2021-02-18
Abstract: Disclosed is a method for producing products from warm dough, which comprises: producing (1) a dough by means of cooking; dispensing (2) the dough into a first container (7) up to a predetermined level; inserting (3), while the dough is warm, a first forming cutting mould (8) provided with a plurality of tubular cells (9) in the shape of the product to be obtained, for example, a croquette, to fill each of the cells with the dough; and rapidly cooling (4), thereby forming the croquettes, which are pushed out by means of a first ejector mould (16) to obtain a plurality of croquettes simultaneously. Any leftover dough is emptied out (2) warm into a second container (7') provided with a movable separator (18), which moves after emptying, until the dough reaches the predetermined level, and the previous steps are repeated.
Patent WO-2023102599-A1 (WO)
Inventor: GARCIA-ROSAS RICARDO
IPC: G09B19/24
Filed: 2022-12-06
Abstract: Des modes de réalisation de l'invention concernent de manière générale un procédé de détermination de métriques de performance d'un utilisateur se rapportant à la commande d'un membre artificiel virtuel dans un environnement de réalité virtuelle ou augmentée. Le procédé consiste à amener un environnement de réalité virtuelle à être présenté à un utilisateur, l'environnement de réalité virtuelle comprenant un membre artificiel virtuel pouvant être commandé par l'utilisateur au moyen d'un dispositif de capteur ; à recevoir des données de capteur en provenance du dispositif de capteur en réponse à l'utilisateur provoquant le déplacement du membre artificiel virtuel dans l'environnement de réalité virtuelle, les données de capteur comprenant des données de capteur de mouvement et des données d'interface de prothèse humaine ; et à traiter les données de capteur pour obtenir au moins une métrique de performance. La ou les métriques de performance sont dérivées par comparaison des données de capteur avec au moins un paramètre prédéterminé, et la ou les métriques de performance concernent un niveau de compétence avec lequel un utilisateur commande le membre artificiel virtuel dans l'environnement de réalité virtuelle.
Patent AU-2022203287-A1 (AU)
Title: Compositions and methods for making benzylisoquinoline alkaloids, morphinan alkaloids, thebaine, and derivatives thereof
Inventor: FACCHINI PETER JAMES
IPC: C12N9/00
Filed: 2022-05-17
Abstract: Disclosed herein are methods that may be used for the synthesis of 
benzylisoquinoline alkaloids (BIAs) such as alkaloid morphinan. The methods 
disclosed can be used to produce thebaine, oripavine, codeine, morphine, oxycodone, 
hydrocodone, oxymorphone, hydromorphone, naltrexone, naloxone, 
hydroxycodeinone, neopinone, and/or buprenorphine. Compositions and organisms 
useful for the synthesis of BIAs, including thebaine synthesis polypeptides, purine 
permeases, and polynucleotides encoding the same, are provided.
Patent AU-2022208361-A1 (AU)
Title: Anti-dll3 antibody-drug conjugate
Inventor: POIRIER JOHN T
IPC: A61K47/68
Filed: 2022-01-13
Abstract: It is an object of the present invention to provide an antibody-drug conjugate of an antibody binding to DLL3 and a drug having antitumor activity, a pharmaceutical composition comprising the antibody-drug conjugate and havoing therapeutic effects on a tumor, a method for treating a tumor using the antibody-drug conjugate or the pharmaceutical composition, and the like. The present invention provides an antibody-drug conjugate of an antibody binding to DLL3 and a drug having antitumor activity, a pharmaceutical composition comprising the antibody or the antibody-drug conjugate, and a method for treating a tumor.
Patent AU-2022228165-A1 (AU)
Title: Pyrrolo [1,2-b] pyridazine derivatives
Inventor: WRIGHT NATHAN E
IPC: A61K31/506
Filed: 2022-09-08
Abstract: Provided is a compound of Formula (I) 
o HN'R1 
R2' N N
H R4 
N 
R5 
Re Re 
5 wherein the variable groups are defined herein.
Patent AU-2022232497-A1 (AU)
Title: METHODS FOR RELIEVING BACK PAIN WITH <i>TERMINALIA CHEBULA</i> COMPOSITIONS
Inventor: KALIDINDI SANYASI R
IPC: A61K31/7048
Filed: 2022-03-09
Abstract: Methods of relieving back pain with
Patent AU-2022240874-A1 (AU)
Title: Drug delivery device
Inventor: Müller Matthias
IPC: A61M5/155
Filed: 2022-03-08
Abstract: A drug delivery device (1), comprising a delivery unit (3) including a drug container (6), a liquid flow system (7), a pumping system (8), and a casing (9) enclosing therein the drug container, the pumping system and at least a part of the liquid flow system, the drug container comprising a barrel portion (6a) and a plunger (12) slidably mounted within the barrel portion and sealing the drug (78) within the container at one end of the barrel portion, the liquid flow system (7) connected fluidical ly to the drug container during delivery of the liquid drug. The drug container is contained within a container receiving cavity (75) of a container casing portion (38) of the casing (9) and the container receiving cavity is fluidically interconnected to a fluid outlet (31) of the pumping system (8) in a gas tight manner, the pumping system comprising a fluid inlet (30) connected to environmental air, the pumping system configured to pump environmental air drawn in through the fluid inlet (30) into the container receiving cavity (75) thus applying pressure on a back end (73) of the plunger for delivery of the liquid drug.
Patent AU-2022259856-A1 (AU)
Title: Systems and methods for predictive diagnostics for mechanical systems
Inventor: MECK KLAUS-DIETER
IPC: G01M13/00
Filed: 2022-10-28
Abstract: SYSTEMS AND METHODS FOR PREDICTIVE DIAGNOSTICS FOR 
MECHANICAL SYSTEMS 
ABSTRACT 
A predictive diagnostics system for monitoring mechanical seals. The system autonomously 
detects a loss of lubrication within a sliding seal interface of a mechanical seal, the system 
including a loss of lubrication failure mode logic module configured to monitor data sensed by 
one or more sensors and diagnose conditions relating to a loss of lubrication within the sliding 
seal interface, and a plurality of other failure mode logic modules configured to monitor data 
sensed by the one or more sensors and diagnose conditions relating to specific types of 
mechanical failures known to occur in mechanical seal systems, the loss of lubrication failure 
mode logic module configured to determine which of the plurality of other failure mode logic 
modules are activated during the diagnosis of conditions related to a loss of lubrication within 
the sliding seal interface.